BCX-4945

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBCX-4945
Drug Alias NameMT-ImmHmethylthio-immucillin-HDADME-Immucillin-Gimmucillin purine nucleoside phosphorylase inhibitors (Biocryst/Medicines for Malaria Venture/Albert Einstein College of Medicine)BCX-4945
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbert Einstein College Of Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals IncAlbert Einstein College Of Medicine Inc
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A